$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

아토피피부염에서 갈근황금황련탕 추출물의 ECS 조절을 통한 염증 완화 효과
Inflammation Relief Effect through ECS Control of Galgeunhwanggeumhwangryeon-tang Extract in Atopic Dermatitis 원문보기

大韓韓方小兒科學會誌 = The journal of pediatrics of Korean medicine, v.35 no.4, 2021년, pp.48 - 55  

김기봉 (부산대학교 한의학전문대학원 한방소아과학교실) ,  안상현 (세명대학교 한의과대학 해부학교실)

Abstract AI-Helper 아이콘AI-Helper

Objective The purpose of this study was to confirm the effects of Galgeunhwanggeumhwangryeon-tang in reducing inflammation through the endocannabinoid system (ECS) control in atopic dermatitis. Methods 8-week-old Balb/C mice were divided into 4 groups: contorl group (Ctrl), lipid barrier elimination...

주제어

표/그림 (4)

참고문헌 (32)

  1. Kim JH. Current understanding of atopic dermatitis. Pediatr Allergy Respir Dis. 2004;14(1):12-23. 

  2. Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England). 2016;387(10023):1109-22. 

  3. Lee JY, Kim DG. The clinical study of atopic dermatitis. J Pediatr Korean Med. 1999;13(2):171-86. 

  4. Jee HM, Kim KW, Kim CS, Sohn MH, Shin DC, Kim KE. Prevalence of asthma, rhinitis and eczema in Korean children using the international study of asthma and allergies in childhood (ISAAC) questionnaires. Pediatr Allergy Respir Dis. 2009;19(2):165-72. 

  5. Ahn KM, Kim JH, Kwon HJ, Chae YM, Hahm MI, Lee KJ, Park YM, Lee SY, Han MY, Kim WK. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011;54(7):769-78. 

  6. Kim MJ, Lee SY. A literature study of atopic dermatitis for children. J Pediatr Korean Med. 2000;14(2):167-82. 

  7. 7. Muluye RA, Bian Y, Alemu PN. Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. J Tradit Complement Med. 2014;4(2):93-8. 

  8. Kim HB, Kang KH, Hwang WD, Lyu SA, Lee SY. The effects of Puerariae Radix on allergic inflammation. J Korean Oriental Pediatrics. 2009;23(3):217-31. 

  9. Ahn SH, Kim KB. Effect of anti-inflammation through creation of skin fat barrier on Scutellaria baicalensis extract. J Pediatr Korean Med. 2021;35(1):40-7. 

  10. Yang BD, Kim SR, Choi CH, Jeoung HW, Kim HW. Effects of Scutellaria baicalensis extract on skin lesion of contact dermatitis induced by DNFB in Mice. J Physiol & Pathol Korean Med. 2017;31(1):59-64. 

  11. Kim YH, Park YS. Effect of Scutellaria baicalensis water extract on antioxidative activity and epidermal thickness in DNCB-induced allergic contact dermatitis animal model. Korean Soc Food Sci Nutr. 2006;35(5):543-8. 

  12. Chin LW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, Chou MC, Yang CC. Anti-herpes simplex virus effects of berberine from Coptidis Rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol 2010;155(12):1933-41. 

  13. Yu YE, Park EY, Jung DH, Byun SH, Kim SC, Park SM. Antibacterial activity of oriental medicinal herb extracts against skin pathogens. J Life Sci. 2010;20(7):1143-50. 

  14. Kim HK, Hong SU. The anti-inflammatory effects of Huang-Lyun (Coptidis Rhizoma, CR) on injured tissue after burn elicitation. J Korean Oriental Med. 2011;32(2):1-13. 

  15. Baron ED, Barzilai D, Johnston G, Kawashima M, Takigawa M, Nakagawa H, Graham-Browh R. Stevens SR. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K. Br J Dermatol. 2002;147:710-5. 

  16. Salzet M. Invertebrate molecular neuroimmune processes. Brain Res Rev, 2000;34(1):69-79. 

  17. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462. 

  18. Kupczyk P, Reich A, Szepietowski JC. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol. 2009;18(8):669-79. 

  19. Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev. 2011;63(3): 461-70. 

  20. Luger TA. Neuromediators--a crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87-93. 

  21. Maccarrone M, Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A. The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem. 2003;278(36):33896-903. 

  22. Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science. 2007; 316(5830):1494-97. 

  23. Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 2003;111(1):43-50. 

  24. Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol. 2005;168:509-54. 

  25. Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol. 2007;152(5):624-32. 

  26. Toth BI, Dobrosi N, Dajnoki A, Czifra G, Olah A, Szollosi AG, Juhasz I, Sugawara K, Paus R, Biro T. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol. 2011;131(5):1095-104. 

  27. Toth KF, Adam D, Biro T, Olah A. Cannabinoid signaling in the skin: therapeutic potential of the "C(ut)annabinoid" system. Molecules. 2019;24(5):918. 

  28. Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med. 2002;30(1) Suppl:s74-9. 

  29. Chung, HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18-30. 

  30. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87(1):13-20. 

  31. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sciences. 2004;75(6):639-53. 

  32. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344(1):30-7. 

저자의 다른 논문 :

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로